Immunopathogenesis of herpetic ocular disease

Immunologic Research

Volumn 16, Issue 4, 1997, Pages 375-386

  Thomas, Johnson ^a   Rouse, Barry T ^a  

^a UNIVERSITY OF TENNESSEE   (United States)

Author keywords

Autoimmunity; Herpes simplex virus (HSV); Herpes stromal keratitis (HSK); Ocular immunopathology

Indexed keywords

CELLULAR IMMUNITY; HERPES SIMPLEX KERATITIS; HERPES SIMPLEX VIRUS; IMMUNOPATHOGENESIS; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; VIRUS LATENCY; VIRUS REACTIVATION;

EID: 0031439721     PISSN: 0257277X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02786400     Document Type: Review

References (75)

1. Roizman B, Sears AK: Herpes simplex virus and their replication; in Fields BN, Knipe DM, Howley PM (eds): Field's Virology. Philadelphia, PA, Lippencott-Raven, 1996, pp 2231-2296.
2. Whitley RJ: Herpes simplex viruses; in Fields BN, Knipe DM, Howley PM (eds): Field's Virology. Philadelphia, PA, Lippencott-Raven, 1996, pp 2297-2342.
3. Pepose JS, Leib DA, Stuart PM, Easty DL: Herpes simplex virus diseases: anterior segment of the eye; in Pepose JS, Holland GN, Wilhelmus KR (eds): Ocular Infection and Immunity. St. Louis, MO, Mosby, 1996, pp 905-932.
4. Streilein JW: Ocular immune privilege and the Faustian dilemma-the Proctor lecture. Invest Ophthalmol Vis Sci 1996;37:1940-1950.
5. Ferguson TA, Griffith TS: Cell death and the immune response - a lesson from the privileged. J Clin Immunol 1997;17:1-10.
6. Liesegang TJ, Melton LJ, Daly PJ, Ilstrup DM: Epidemiology of ocular herpes simplex. Incidence in Rochester, Minn, 1950 through 1982. Arch Ophthalmol 1989;107: 1155-1159.
7. Rouse BT: Virus induced immunopathology. Adv Virus Res 1996; 47:353-376.
8. Josey WE: Genital infection with type 2 herpes virus hominis. Am J Obstet Gynecol 1968;101:718.
9. Corey L, Adams H, Brown A, Holmes K: Genital herpes simplex virus infections: Clinical manifestations, course and complications. Ann Intern Med 1983;98: 958-972.
10. Mester JC, Milligan GN, Bernstein DI: Immunology of herpes simplex virus;in Stanberry LR (ed): Genital and Neonatal Herpes. Wiley, New York, 1996, pp 49-91
11. Lopez C: Resistance to herpes simplex virus-lype 1 (HSV-1). Curr Top Microbiol Immunol 1981;92:15-24.
12. Lopez C, Kirkpatrick D, Read SE, Fitzgerald PA, Pitt J, Pahwa S, Ching CY, Smithwick EM: Correlation between low natural killing of fibroblasts infected with herpes simplex virus type-1 and susceptibility to herpesvirus infections. J Infect Dis 1983; 147:1030-1035.
13. Schmid DS, Rouse BT: The role of Tcell imnnunity in control of herpes simplex virus. Curr Top Microbiol Immunol 1992;179:57-74.
14. Rasmussen L, Merigan TC: Role of T-lymphocytes in cellular immune responses during herpes simplex virus infection in humans. J Immunol 1974;112:728-734.
15. Wildy PJ, Gell PG: The host response to herpes simplex virus. Br Med Bull 1985;41:86-91.
16. Roizman B, Sears AK: An enquiry into the mechanisms of herpes simplex virus latency. Ann Rev Microbiol 1987; 41:543-571.
17. Fraser NW, Spivack JG, Wroblewska Z, Block T, Deshmane SL, Valyi-Nagi T, Natarajan R, Gesser RM: A review of the molecular mechanism of HSV-1 latency. Curr Eye Res 1991;10(Suppl):1-13.
18. Ho DY: Herpes simplex virus latency: Molecular aspects. Prog Med Virol 1992;39:76-115
19. Hill TJ: Herpes simplex virus latency. in Roizman B (ed) The Herpes Viruses. New York, Plenum, 1985, pp 175-240.
20. Sundmacher R, Neumann-Haefelin D: Herpes simplex virus - positive and negative keratouveitis. in Silverstein AM, O'Connor R (eds). Immunology and Immunopathology of the Eye. New York, Masson, 1979, pp 225-229.
21. Oh JO: Primary and secondary herpes simplex uveitis in rabbits. Surv Ophthalmol 1976;21:178-184.
22. Margolis TP, Atherton SS: Herpes simplex virus diseases: posterior segment of the eye; in Pepose JS, Holland GN, Wilhelmus KR (eds): Ocular Infection and Immunity. St. Louis, MO, Mosby 1996, pp 1155-1167.
23. Azumi A, Cousins SW, Kanter MY, Atherton SS. Modulation of murine herpes simplex virus; type 1 retinitis in the uninoculated eye by CD4+ T lymphocytes. Invest Ophthalmol Vis Sci 1994;35:54-63.
24. Vann VR, Atherton SS. Neural spread of herpes simplex virus after anterior chamber inoculation. Invest Ophthalmol Vis Sci 1991;32:2462-2472.
25. Azumi A, Atherton SS. Sparing of the ipsilateral retina after anterior chamber inoculation of HSV-1: requirement for either CD4+ or CD8+ T cells. Invest Ophthalmol Vis Sci 1994;35:3251-3259.
26. Liesegang TJ: Epidemiology of ocular herpes simplex. Natural history in Rochester, Minn, 1950 through 1982. Arch Ophthalmol. 1989;107:1160-1165.
27. Kaufman HE, Nesburn AB, Maloney ED: IDIJ therapy of herpes simplex. Arch Ophthalmol 1962;67:583-591.
28. Swyers JS, Lausch RN, Kaufman HE: Corneal hypersensitivity to herpes simplex. Br J Ophthalmol 1967;51:843-846.
29. Meyers-Elliott RH, Chitjian PA: Immunopathogenesis of corneal inflammation in herpes simplex virus stromal keratitis: role of the polymorphonuclear leukocyte. Invest Ophthalmol Vis Sci 1981; 20:784-798.
30. Dawson CR, Togni B: Herpes simplex eye iniections. Clinical manifestations, pathogenesis and management. Surv Ophthalmol 1976;21:121-135.
31. Doymaz MZ, Rouse BT: Immunopathology of herpes simplex virus infections. Curr Top Microbiol Immunol 1992;179:121-136.
32. Babu JS, Rouse BT: Inflammatory disease in the T cell mediated immunopathology - the herpetic stromal keratitis example. Allergy Immunol (Life Sci. Adv) 1996;13: 109-116.
33. Rouse BT, Atherton SS: Immunopathology of herpes virus infections. in Medveczky P, Bendinelli M, Friedman H (eds): Infectious Agents and Pathogenesis. New York, Plenum Press, 1997, submitted.
34. Mester JC, Rouse BT: The mouse model and understanding immunity to herpes simplex virus. Rev Infect Dis 1991;13(Suppl 11): S935-45.
35. Laycock KA, Lee SF, Brady RH, Pepose JS: Characterization of a murine model of recurrent herpetic keratitis induced by ultraviolet B radiation. Invest Ophthalmol Vis Sci 1991;32:2741-2746.
36. Shimeld C, Hill TJ, Blyth WA, Easty DL: Reactivation of latent infection and induction of recurrent herpet∼c eye disease in mice. J Gen Virol 1990;71:397-404.
37. Miller JK, Laycock KA, Umphress JA, Hook KK, Stuart PM, Pepose JS: A comparison of recurrent and primary herpes simplex keratitis in NIH inbred mice. Cornea 1996; 15:497-504.
38. Miller JK, Laycock KA, Nash MM, Pepose J: Corneal Langerhans cell dynamics after herpes simplex virus reactivation. Invest Ophthalmol Vis Sci 1993;34:2282-2290
39. Shimeld C, Whiteland JL, Nicholls SM, Easty DL, Hill TJ: Immune cell infiltration in corneas of mice with recurrent herpes simplex virus disease. J Gen Virol 1996; 77:977-985
40. Thomas J, Gangappa S, Kanangat S, Rouse BT: On the essential involvement of neutrophils in the immunopathological disease -herpetic stromal keratitis. J Immunol 1997;158:1383-1391
41. Babu JS, Kanangat S, Rouse BT: T cell cytokiine mRNA expression during the course of the immunopathologic ocular disease - herpetic stromal keratitis. J Immunol 1995;154:4822-4829.
42. Metcalf JF, Hamilton DS, Reichert RW: Herpetic keratitis in athymic (nude) mice. Infect Immunol 1979;26:1164-1171.
43. Russel RG, Nasisse MP, Larsen HS, Rouse BT: Role of T-lymphocytes in the pathogenesis of herpetic stromal keratitis. Invest Ophthalmol Vis Sci 1984;25:938-944.
44. Newell CK, Martin S, Sendele D, Mercadal CPM, Rouse BT: Herpes simplex virus induced stromal keratitis: role of T lymphocyte subsets in immunopathology. J Virol 1989;63:769-775.
45. Newell CK, Sendele D, Rouse BT: Effects of CD4+ and CD8+ T-lymphocyte depletion on the induction and expression of herpes simplex stromal keratitis. Reg Immunol 1989;2:366-369.
46. Doymaz MZ, Rouse BT: Herpetic stromal keratitis: an immunopathological disease mediated by CD4+ T lymphocytes. Invest Ophthalmol Vis Sci 1992;33:2165-2173.
47. Mercadal C, Bouley D, DeStephano D, Rouse BT: Herpetic stromal keratitis in the reconstituted SCID mouse model. J Virol 1993;67: 3404-3408.
48. Hendricks RL, Tumpey TM: Contribution of virus and immune factors to herpes simplex virus type I induced corneal pathology. Invest Ophthalmol Vis Sci 1990; 31:1929-1939.
49. Niemialtowski MG, Rouse BT: Phenotypic and functional studies on ocular T cells during herpetic infections of the eye. J Immunol 199:2;149:3035-3039.
50. Yasukawa M, Zarling JM: Human cytotoxic T cell clones directed against herpes simplex virus infected cells. I. Lysis restricted by HLA class II MB and DR antigens. J Immunol 1984;133: 422-427.
51. Buchrneier MJ, Welsh RM, Dutko FJ, Oldstone MBA: The virology and immunobiology of lymphocytic choriomeningitis virus infection. Adv Immunol 1980;30:275-331.
52. Jaeschke H, Smith CW: Mechanisms of neutrophil induced parenchymal cell injury. J Leukoc Biol 1997;61: 647-653.
53. Niemialtowski MG, Rouse BT: Predominance of Th-1 cells in ocular tissues during herpetic stromal keratitis. J Immunol 1992;149:3035-3039.
54. Hendricks RL, Tumpey TM, Finnegan A: IFN-gamma and IL-2 are protective in the skin but pathologic in the corneas of HSV-1 infected mice. J Immunol 1992;149:3023-3028.
55. Manickan E, Rouse RJD, Yu Z, Wire WS, Rouse BT: Genetic immunization against herpes simplex virus. Protection is mediated by CD4+T cells. J Immunol 1995; 155:259-265.
56. Geiger K, Howes E, Gallina M, Huang XJ, Travis GH, Sarvetnick N: Transgenic mice expressing IFN-gamma in the retina develop inflammation of the eye and photoreceptor loss. Invest Ophthalmol Vis Sci 1994;35:2667-2681.
57. Sarvetnick N, Shizuru J, Liggit D, Martin L, McIntyre B, Gregory A, Parslow T, Stewart T: Loss of pancreatic islet tolerance induced by beta-cell expression of interferon-gamma. Nature 1990;346: 844-847.
58. Minamoto S,Treisman J, Hankins WD, Sugamura K, Rosenberg SA: Acquired erythropoietin responsiveness of interleukin-2 dependent T lymphocytes retrovirally transduced with genes encoding chimeric erythropoietin/interleukin-2 receptors. Blood 1995; 86:2281-2287.
59. Tang Q, Chen W. Hendricks RL: Proinflammatory functions of IL-2 in herpes simplex virus corneal infection. J Immunol 1997;158:1275-1283.
60. Bouley DM, Kanangat S, Wire W, Rouse BT: Characterization of herpes simplex virus type 1 infection and herpetic stromal keratitis development in IFN-gamma knockout mice. J Immunol 1995;155: 3964-3971.
61. Steinman L: Some misconceptions about understanding autoimmunity through experiments with knockouts. J Exp Med 1997;185:2039-2041.
62. Tumpey TM, Chen SH, Oakes JE, Lausch RN: Neutrophil mediated suppression of virus replication after herpes simplex virus type 1 infection of the murine cornea. J Virol 1996;70:898-904.
63. Su YH, Yan XT, Oakes JE, Lausch RN: Protective antibody therapy is associated with reduced chemokine transcripts in herpes simplex virus type 1 corneal infection. J Virol 1996; 70: 1277-1281.
64. Chen W, Tang Q, Hendricks R: Ex Vivo model of leukocyte migration into herpes simple virus infected mouse corneas. J Leukoc Biol 1996;60:167-173.
65. Tang Q, Hendricks RL: Interferon gamma regulates platelet endothelial cell adhesion molecule 1 expression and neutrophil infiltration into herpes simplex virus infected mouse corneas. J Exp Med 1996;184: 1435-1447.
66. Kanangat S, Thomas J, Gangappa S, Babu J, Rouse BT: Herpes simplex virus type 1 mediated upregulation of IL-12 (p40, mRNA expression. Implications in immunopathogenesis and protection. J Immunol 1995;156:1110-1116.
67. Brennan FM, Feldmann M: Cytokines in a,utoimmunity. Curr Opinion Immunol 1996;8:872-877.
68. Nathan C, Xie Q: Nitric Oxide syntheses Roles, tolls and controls: Cell 1994;78:915-918.
69. Tumpey TM, Elner VM, Chen SH, Oakes JE, Lausch RN: Interleukin-10 treatment can suppress stromal keratitis induced by herpes simplex virus type 1. J Immunol 1994;153:2258-2265.
70. Daheshia M, Kuklin N, Kanangat S, Manickan E, Rouse BT: Suppression of ongoing ocular inflammatory disease by topical administration of plasmid DNA encoding IL-10: J Immunol 1997; 159: 1945-1952.
71. Tumpey TM, Cheng H, Yan XT, Oakes JE, Lausch RN: Local administration of IL-10 suppresses chemokine synthesis and reduces severity of HSV-1 induced keratitis. Invest Ophthalmol Vis Sci 1997;38:abstract#3343:S724.
72. Babu JS, Thomas J, Kanangat S, Morrison LA, Knipe DM, Rouse BT: Viral replication is required for induction of ocular immunopathology by herpes simplex virus. J Virol 1996;70:101-107.
73. Hendricks RL, Janowicz M, Tumpey TM: Critical role of corneal Langerhans cells in the CD4+ mediated but not CDS+ mediated immunopathology in herpes simplex virus-1 infected mouse corneas. J Immunol 1992; 148:2522-2529.
74. Avery AC, Zhao ZS, Rodriquez A, Bikoff EK., Soheilian M, Foster CS, Cantor H: Resistance to herpes stromal keratitis conferred by an IgG2a derived peptide. Nature 1995;376:431-434.
75. Casanova JL, Romero P, Widmann C, Kourilsky P. Maryanski JL: Tcell receptor genes in a series of class I major histocompatibility complex-restricted cytotoxic T lymphocyte clones specific for a Plasmodium berghei nonapeptide: implications for T cell allelic exclusion and antigen-specific repertoire. J Exp Med 1991;174: 1371-1383.